FRESENIUS MEDICAL CARE-ADR (FMS) Fundamental Analysis & Valuation
NYSE:FMS • US3580291066
Current stock price
22.06 USD
-0.33 (-1.47%)
At close:
22.06 USD
0 (0%)
After Hours:
This FMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FMS Profitability Analysis
1.1 Basic Checks
- FMS had positive earnings in the past year.
- FMS had a positive operating cash flow in the past year.
- In the past 5 years FMS has always been profitable.
- Each year in the past 5 years FMS had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.16%, FMS is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
- FMS has a Return On Equity of 7.35%. This is in the better half of the industry: FMS outperforms 63.00% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 5.30%, FMS is in line with its industry, outperforming 58.00% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for FMS is below the industry average of 8.85%.
- The last Return On Invested Capital (5.30%) for FMS is above the 3 year average (4.02%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROIC | 5.3% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
1.3 Margins
- The Profit Margin of FMS (4.98%) is better than 77.00% of its industry peers.
- FMS's Profit Margin has declined in the last couple of years.
- FMS's Operating Margin of 9.00% is fine compared to the rest of the industry. FMS outperforms 77.00% of its industry peers.
- In the last couple of years the Operating Margin of FMS has declined.
- FMS has a Gross Margin (25.62%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% |
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
2. FMS Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FMS is still creating some value.
- Compared to 1 year ago, FMS has less shares outstanding
- Compared to 5 years ago, FMS has less shares outstanding
- The debt/assets ratio for FMS is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.80, we must say that FMS is in the distress zone and has some risk of bankruptcy.
- FMS has a Altman-Z score (1.80) which is comparable to the rest of the industry.
- FMS has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FMS would need 6.19 years to pay back of all of its debts.
- The Debt to FCF ratio of FMS (6.19) is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.65 indicates that FMS is somewhat dependend on debt financing.
- FMS has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: FMS outperforms 56.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Altman-Z | 1.8 |
ROIC/WACC1.04
WACC5.11%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that FMS should not have too much problems paying its short term obligations.
- FMS's Current ratio of 1.26 is in line compared to the rest of the industry. FMS outperforms 47.00% of its industry peers.
- A Quick Ratio of 0.92 indicates that FMS may have some problems paying its short term obligations.
- FMS has a worse Quick ratio (0.92) than 72.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 |
3. FMS Growth Analysis
3.1 Past
- FMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
- FMS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.51% yearly.
- FMS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.51%.
- The Revenue has been growing slightly by 1.91% on average over the past years.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
3.2 Future
- The Earnings Per Share is expected to grow by 9.03% on average over the next years. This is quite good.
- FMS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.69% yearly.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. FMS Valuation Analysis
4.1 Price/Earnings Ratio
- FMS is valuated reasonably with a Price/Earnings ratio of 8.72.
- FMS's Price/Earnings ratio is rather cheap when compared to the industry. FMS is cheaper than 95.00% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 24.88. FMS is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 9.32, the valuation of FMS can be described as very reasonable.
- 92.00% of the companies in the same industry are more expensive than FMS, based on the Price/Forward Earnings ratio.
- FMS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.72 | ||
| Fwd PE | 9.32 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 91.00% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 92.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.12 | ||
| EV/EBITDA | 5.86 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%
5. FMS Dividend Analysis
5.1 Amount
- FMS has a Yearly Dividend Yield of 3.70%.
- FMS's Dividend Yield is rather good when compared to the industry average which is at 0.50. FMS pays more dividend than 99.00% of the companies in the same industry.
- FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
5.2 History
- The dividend of FMS has a limited annual growth rate of 4.43%.
- FMS has been paying a dividend for at least 10 years, so it has a reliable track record.
- The dividend of FMS decreased in the last 3 years.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- FMS pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
- FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FMS Fundamentals: All Metrics, Ratios and Statistics
22.06
-0.33 (-1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24 2026-02-24/dmh
Earnings (Next)05-05 2026-05-05
Inst Owners44.27%
Inst Owner Change6.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.32B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target27.2 (23.3%)
Short Float %0.5%
Short Ratio3.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.7% |
Yearly Dividend0.87
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)0.14%
PT rev (3m)-2.47%
EPS NQ rev (1m)33.91%
EPS NQ rev (3m)33.91%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)-5.71%
Revenue NQ rev (3m)-5.71%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-2.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.72 | ||
| Fwd PE | 9.32 | ||
| P/S | 0.54 | ||
| P/FCF | 6.12 | ||
| P/OCF | 3.98 | ||
| P/B | 0.8 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.86 |
EPS(TTM)2.53
EY11.47%
EPS(NY)2.37
Fwd EY10.73%
FCF(TTM)3.6
FCFY16.33%
OCF(TTM)5.54
OCFY25.11%
SpS40.55
BVpS27.5
TBVpS-3.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number39.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROCE | 7.13% | ||
| ROIC | 5.3% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 16.63% | ||
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% | ||
| FCFM | 8.88% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Debt/EBITDA | 2.64 | ||
| Cap/Depr | 62.47% | ||
| Cap/Sales | 4.78% | ||
| Interest Coverage | 4.9 | ||
| Cash Conversion | 82.09% | ||
| Profit Quality | 178.22% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.8 |
F-Score8
WACC5.11%
ROIC/WACC1.04
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year71.81%
EBIT Next 3Y24.11%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%
FRESENIUS MEDICAL CARE-ADR / FMS Fundamental Analysis FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
What is the profitability of FMS stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to decline by -6.53% in the next year.
Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?
The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 43.19%.